Astrana Health, Inc. Reports Fourth Quarter and Year-End 2024 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Astrana Health, Inc (ASTH) PT Lowered to $49 at BofA Securities
March 3, 2025 1:40 PM ESTBofA Securities analyst Adam ROn lowered the price target on Astrana Health, Inc (NASDAQ: ASTH) to $49.00 (from $55.00) while maintaining a Buy rating.
The analyst comments "ASTH reported somewhat mixed 4Q results. Despite roughly hitting consensus EBITDA estimates, the company missed its... More
